183 related articles for article (PubMed ID: 29532430)
21. Transnasal transsphenoidal pituitary surgery in a large tertiary hospital, a retrospective study.
Nys C; Versyck G; Buelens E; Engelborghs K; Cornips E; Van Leeuwen-Wintjens H; Vankelecom H; Weyns F; Peuskens D
Acta Chir Belg; 2023 Jun; 123(3):272-280. PubMed ID: 34590931
[TBL] [Abstract][Full Text] [Related]
22. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
23. Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal.
Tortosa F; Webb SM
Neurologia; 2016 Mar; 31(2):97-105. PubMed ID: 26300499
[TBL] [Abstract][Full Text] [Related]
24. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between invasive pituitary adenomas and cavernus sinus and cariod artery and surgical outcomes].
Ren ZY; Yang Y; Su CB; Wang RZ; Tao W; Ma WB; Li YN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):13-7. PubMed ID: 15782485
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
27. Pituitary adenomas in children and young adults.
Krajewski KL; Rotermund R; Flitsch J
Childs Nerv Syst; 2018 Sep; 34(9):1691-1696. PubMed ID: 29850940
[TBL] [Abstract][Full Text] [Related]
28. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[TBL] [Abstract][Full Text] [Related]
29. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
30. Adrenal Axis Insufficiency After Endoscopic Transsphenoidal Resection of Pituitary Adenomas.
Ajlan A; Almufawez KA; Albakr A; Katznelson L; Harsh GR
World Neurosurg; 2018 Apr; 112():e869-e875. PubMed ID: 29421453
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
32. Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery.
Wichers-Rother M; Hoven S; Kristof RA; Bliesener N; Stoffel-Wagner B
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):323-7. PubMed ID: 15216450
[TBL] [Abstract][Full Text] [Related]
33. Pituitary tumours - a large retrospective single-centre study of over 2300 cases. Experience of a tertiary reference centre.
Rak B; Maksymowicz M; Grzywa TM; Sajjad E; Pękul M; Włodarski P; Zieliński G
Endokrynol Pol; 2020; 71(2):116-125. PubMed ID: 32154573
[TBL] [Abstract][Full Text] [Related]
34. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.
Iglesias P; Rodríguez Berrocal V; Díez JJ
Endocrine; 2018 Sep; 61(3):407-421. PubMed ID: 29909598
[TBL] [Abstract][Full Text] [Related]
35. Gender differences in presentation and outcome of nonfunctioning pituitary macroadenomas.
Caputo C; Sutherland T; Farish S; McNeill P; Ng KW; Inder WJ
Clin Endocrinol (Oxf); 2013 Apr; 78(4):564-70. PubMed ID: 22889015
[TBL] [Abstract][Full Text] [Related]
36. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G
Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series.
Cavallo LM; Solari D; Tasiou A; Esposito F; de Angelis M; D'Enza AI; Cappabianca P
World Neurosurg; 2013; 80(3-4):342-50. PubMed ID: 23046913
[TBL] [Abstract][Full Text] [Related]
38. Surgical management of selected pituitary macroadenomas using extended endoscopic endonasal transsphenoidal approach: early experience.
Sankhla SK; Jayashankar N; Khan GM
Neurol India; 2013; 61(2):122-30. PubMed ID: 23644310
[TBL] [Abstract][Full Text] [Related]
39. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
40. Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade.
Chinezu R; Fomekong F; Lasolle H; Trouillas J; Vasiljevic A; Raverot G; Jouanneau E
World Neurosurg; 2017 Oct; 106():315-321. PubMed ID: 28676462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
